CG
IBB icon

Caprock Group’s iShares Biotechnology ETF IBB Stock Holding History

Caprock Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,614
Closed -$610K – 1193
2025
Q4 		$610K Buy
3,614
+61
+2% +$9.91K 0.01% 754
2025
Q3 		$491K Buy
+3,553
New +$485K 0.01% 813
2025
Q1 		$423K Sell
3,308
-36
-1% -$4.88K 0.01% 782
2024
Q4 		$442K Buy
+3,344
New +$470K 0.01% 664
2024
Q3 		– Sell
-3,475
Closed -$477K – 937
2024
Q2 		$477K Sell
3,475
-27
-0.8% -$3.6K 0.02% 545
2024
Q1 		$481K Buy
3,502
+6
+0.2% +$819 0.03% 426
2023
Q4 		$475K Buy
3,496
+26
+0.7% +$3.17K 0.03% 399
2023
Q3 		$425K Hold
3,470
– – 0.03% 396
2023
Q2 		$441K Sell
3,470
-145
-4% -$18.8K 0.03% 404
2023
Q1 		$467K Hold
3,615
– – 0.04% 381
2022
Q4 		$475K Sell
3,615
-540
-13% -$69.8K 0.04% 292
2022
Q3 		$486K Sell
4,155
-566
-12% -$70.3K 0.05% 280
2022
Q2 		$555K Sell
4,721
-205
-4% -$24.3K 0.05% 250
2022
Q1 		$642K Buy
4,926
+48
+1% +$6.25K 0.06% 245
2021
Q4 		$744K Sell
4,878
-4,313
-47% -$668K 0.06% 220
2021
Q3 		$1.49M Sell
9,191
-2,666
-22% -$449K 0.13% 109
2021
Q2 		$1.94M Sell
11,857
-10,316
-47% -$1.59M 0.18% 87
2021
Q1 		$3.34M Buy
22,173
+2,997
+16% +$476K 0.37% 46
2020
Q4 		$2.9M Buy
19,176
+3,734
+24% +$534K 0.33% 53
2020
Q3 		$2.09M Buy
15,442
+7,460
+93% +$1.01M 0.29% 62
2020
Q2 		$1.09M Buy
7,982
+4,754
+147% +$606K 0.16% 109
2020
Q1 		$348K Sell
3,228
-31,827
-91% -$3.66M 0.07% 208
2019
Q4 		$4.22M Sell
35,055
-10,937
-24% -$1.22M 0.76% 24
2019
Q3 		$4.58M Buy
45,992
+7,083
+18% +$741K 0.89% 20
2019
Q2 		$4.25M Buy
38,909
+3,942
+11% +$419K 0.83% 21
2019
Q1 		$3.91M Buy
34,967
+1,059
+3% +$116K 0.76% 22
2018
Q4 		$3.27M Buy
33,908
+4,832
+17% +$513K 0.75% 22
2018
Q3 		$3.55M Sell
29,076
-1,174
-4% -$138K 0.72% 23
2018
Q2 		$3.33M Buy
30,250
+868
+3% +$92.8K 0.7% 22
2018
Q1 		$3.14M Buy
29,382
+2,871
+11% +$318K 0.67% 23
2017
Q4 		$2.97M Buy
26,511
+1,386
+6% +$148K 0.58% 30
2017
Q3 		$2.79M Buy
25,125
+3,603
+17% +$385K 0.58% 30
2017
Q2 		$2.23M Buy
21,522
+7,635
+55% +$752K 0.49% 36
2017
Q1 		$1.36M Buy
13,887
+1,044
+8% +$99.9K 0.32% 55
2016
Q4 		$1.14M Buy
12,843
+7,257
+130% +$660K 0.29% 72
2016
Q3 		$539K Sell
5,586
-9,309
-62% -$886K 0.12% 154
2016
Q2 		$1.28M Sell
14,895
-141
-0.9% -$12.7K 0.31% 81
2016
Q1 		$1.31M Buy
15,036
+7,791
+108% +$697K 0.31% 69
2015
Q4 		$817K Buy
7,245
+294
+4% +$31.9K 0.47% 38
2015
Q3 		$703K Sell
6,951
-4,155
-37% -$498K 0.5% 35
2015
Q2 		$1.37M Sell
11,106
-237
-2% -$28.4K 1.25% 20
2015
Q1 		$1.3M Buy
11,343
+6,519
+135% +$719K 1.33% 19
2014
Q4 		$488K Buy
+4,824
New +$469K 0.53% 44

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caprock Group's IBB Position: Q1 2026 in Review

Caprock Group sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 3,614 shares — an estimated $610K sold.

Caprock Group first reported a position in IBB in Q4 2014 and held it in 43 quarters. The position peaked at $4.58M in Q3 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Caprock Group reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Caprock Group sold 3,614 iShares Biotechnology ETF shares in Q1 2026, an estimated $610K.
  • Caprock Group first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 43 quarters.
  • Caprock Group's iShares Biotechnology ETF position peaked at $4.58M in Q3 2019.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.